Stockscreener 앱 받기
3.01
6.36%
0.18
시간 외 거래:
3.01
전일 마감가:
$2.83
열려 있는:
$2.85
하루 거래량:
377.90K
Relative Volume:
2.50
시가총액:
$141.86M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+11.07%
1개월 성능:
+17.12%
6개월 성능:
+76.02%
1년 성능:
+0.00%
1일 변동 폭
$2.8301
$3.03
1주일 범위
$2.63
$3.03
52주 변동 폭
$1.39
$3.7699
Whitehawk Therapeutics Inc Stock (WHWK) Company Profile
명칭
Whitehawk Therapeutics Inc
전화
551-321-2234
주소
2 HEADQUARTERS PLAZA, MORRISTOWN
Compare WHWK vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
WHWK
Whitehawk Therapeutics Inc
|
3.01 | 133.37M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Whitehawk Therapeutics Inc Stock (WHWK) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-05 | 개시 | Oppenheimer | Outperform |
| 2024-08-27 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2024-08-21 | 다운그레이드 | Jefferies | Buy → Hold |
| 2024-08-21 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2023-12-15 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2022-01-11 | 개시 | Jefferies | Buy |
| 2021-10-01 | 개시 | Cowen | Outperform |
| 2021-09-14 | 개시 | Ladenburg Thalmann | Buy |
| 2021-09-08 | 개시 | Piper Sandler | Overweight |
모두보기
Whitehawk Therapeutics Inc 주식(WHWK)의 최신 뉴스
Oppenheimer Begins Coverage on Whitehawk Therapeutics (NASDAQ:WHWK) - Defense World
Oppenheimer initiates Whitehawk Therapeutics (WHWK) with Outperform Feb 2026 - Meyka
Oppenheimer Initiates Coverage on Whitehawk Therapeutics (NASDAQ:WHWK) - MarketBeat
Whitehawk Therapeutics (NASDAQ:WHWK) Trading 0.7% HigherStill a Buy? - MarketBeat
Retail Trends: Can FreightCar America Inc be recession proofJuly 2025 Market Mood & Low Risk Profit Maximizing Plans - baoquankhu1.vn
Aug Reactions: Will Whitehawk Therapeutics Inc outperform tech stocks2025 Price Action Summary & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn
Will Whitehawk Therapeutics Inc outperform the market in YEAR2025 Key Highlights & High Conviction Trade Alerts - baoquankhu1.vn
Investment Recap: Will Whitehawk Therapeutics Inc outperform the market in YEAR2025 Investor Takeaways & Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Whitehawk Therapeutics (WHWK) price target increased by 125.00% to 4.59 - MSN
Support Test: Should I set a stop loss on Onfolio Holdings IncTake Profit & Free Safe Entry Trade Signal Reports - baoquankhu1.vn
Can Whitehawk Therapeutics Inc sustain its profitability2025 Pullback Review & Weekly Sector Rotation Insights - baoquankhu1.vn
Whitehawk Therapeutics, Inc. (NASDAQ:WHWK) Shares Fly 27% But Investors Aren't Buying For Growth - simplywall.st
Whitehawk Therapeutics (NASDAQ:WHWK) Stock Price Down 2.7%Here's What Happened - MarketBeat
Whitehawk Therapeutics (NASDAQ:WHWK) Stock Price Down 2.7% – Here’s What Happened - Defense World
Published on: 2026-01-10 19:11:09 - ulpravda.ru
Why Whitehawk Therapeutics Inc. stock is favored by top institutionsJuly 2025 Technicals & Reliable Trade Execution Plans - Улправда
Following a 26% decline over last year, recent gains may please Whitehawk Therapeutics, Inc. (NASDAQ:WHWK) hedge funds owners - Sahm
Will Whitehawk Therapeutics Inc. stock continue upward momentumJuly 2025 Chart Watch & Verified Stock Trade Ideas - ulpravda.ru
Why Whitehawk Therapeutics Inc. stock attracts high net worth investorsWeekly Profit Summary & Free Expert Approved Momentum Trade Ideas - Улправда
How Whitehawk Therapeutics Inc. stock performs in rate cut cyclesPortfolio Growth Summary & Free Safe Entry Trade Signal Reports - ulpravda.ru
Will Whitehawk Therapeutics Inc. stock pay special dividendsEarnings Growth Summary & Weekly High Return Stock Opportunities - ulpravda.ru
Why institutional investors increase stakes in Whitehawk Therapeutics Inc. (3350) stockJuly 2025 EndofMonth & Community Trade Idea Sharing - Улправда
Whitehawk receives FDA clearance for PTK7-targeted cancer drug - Investing.com
Whitehawk Therapeutics Advances to Clinical Stage with IND Clearance for HWK-007 and Announces IND Submission for HWK-016 - The AI Journal
Published on: 2026-01-07 23:20:08 - Улправда
Can Whitehawk Therapeutics Inc. stock weather global recessionCandlestick Trading Patterns & Access Powerful Market Insights - Улправда
Free cash flow per share of Whitehawk Therapeutics, Inc. – DUS:3350 - TradingView — Track All Markets
Whitehawk Therapeutics, Inc.Common Stock (Nasdaq:WHWK) Stock Quote - FinancialContent
Whitehawk Therapeutics (NASDAQ:WHWK) Now Covered by Jones Trading - MarketBeat
Whitehawk Therapeutics (WHWK) Receives Buy Rating from Jones Tra - GuruFocus
Jones Trading initiates coverage on Whitehawk Therapeutics stock with Buy rating - Investing.com Canada
Published on: 2025-12-21 14:50:11 - Улправда
Analyzing Whitehawk Therapeutics (NASDAQ:WHWK) & Vaccinex (NASDAQ:VCNX) - Defense World
Will Whitehawk Therapeutics Inc. stock recover faster than market2025 Earnings Surprises & Detailed Earnings Play Alerts - Улправда
Will Whitehawk Therapeutics Inc. (3350) stock test record highs in 2025July 2025 Setups & Smart Investment Allocation Tips - Улправда
Will Whitehawk Therapeutics Inc. stock maintain momentum in 2025Market Sentiment Summary & Weekly Breakout Stock Alerts - ulpravda.ru
What risks investors should watch in Whitehawk Therapeutics Inc. stockJuly 2025 Fed Impact & Community Trade Idea Sharing Platform - Улправда
Published on: 2025-12-19 20:40:41 - Улправда
Investment Recap: Will Whitehawk Therapeutics Inc. stock maintain momentum in 20252025 Short Interest & Weekly Breakout Watchlists - Улправда
Is Whitehawk Therapeutics Inc. stock a buy for dividend growthJuly 2025 EndofMonth & Long-Term Safe Return Strategies - DonanımHaber
Can Whitehawk Therapeutics Inc. (3350) stock double in coming yearsMarket Risk Analysis & Weekly High Conviction Ideas - DonanımHaber
Why Whitehawk Therapeutics Inc. stock remains resilientQuarterly Trade Review & Breakout Confirmation Alerts - Улправда
How interest rate cuts could boost Whitehawk Therapeutics Inc. stockOil Prices & Weekly Setup with ROI Potential - ulpravda.ru
What macro factors could drive Whitehawk Therapeutics Inc. (3350) stock higher2025 Sector Review & Stepwise Swing Trade Plans - Улправда
Is Whitehawk Therapeutics Inc. stock a dividend growth opportunityPortfolio Return Summary & Real-Time Market Sentiment Reports - Улправда
Whitehawk Therapeutics Earnings Notes - Trefis
Bond Watch: Is Whitehawk Therapeutics Inc stock a top pick in earnings seasonMarket Sentiment Review & Entry Point Strategy Guides - moha.gov.vn
Financial Comparison: Whitehawk Therapeutics (NASDAQ:WHWK) vs. BetterLife Pharma (OTCMKTS:PVOTF) - Defense World
Shorts Report: What risks investors should watch in Whitehawk Therapeutics Inc stockExit Point & Smart Investment Allocation Tips - moha.gov.vn
Will Whitehawk Therapeutics Inc. (3350) stock profit from automation waveStop Loss & Daily Stock Trend Reports - Newser
What makes Whitehawk Therapeutics Inc. stock attractive to growth fundsJuly 2025 Decliners & Low Risk High Reward Ideas - Newser
Whitehawk Therapeutics Inc (WHWK) 재무 분석
Whitehawk Therapeutics Inc (WHWK)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
1.24%
0.19%
자본화:
|
볼륨(24시간):